Cohance Life

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE03QK01018
NSEID: COHANCE
BSEID: 543064

INR

537.05

6.7 (1.26%)

BSENSE

Dec 16

BSE+NSE Vol: 21.0 lacs

{
  "main_header": {
    "sid": 1003386,
    "name": "Cohance Life",
    "stock_name": "Cohance Life",
    "full_name": "Cohance Lifesciences Ltd",
    "name_url": "stocks-analysis/cohance-life",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "537.05",
    "chg": 6.7,
    "chgp": "1.26%",
    "dir": 1,
    "prev_price": "530.35",
    "mcapval": "20,435.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543064,
    "symbol": "COHANCE",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE03QK01018",
    "curr_date": "Dec 16",
    "curr_time": "",
    "bse_nse_vol": "21.0 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 16, 2025",
    "traded_date_str": "2025 12 16",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/cohance-life-1003386-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Cohance Life falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-cohance-life-fallingrising-3754501",
        "imagepath": "",
        "date": "2025-12-10 00:56:29",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Dynamics and Market Context</strong></p>\n<p>On 09 December, Cohance Lifesciences demonstrated a slight recovery, gaining ₹4.80 or 0.9% after a period of downward pressure. Notably, the stock hit a fresh 52-week low of ₹521.45 during the day, signalling persistent weakness. Despite this, the stock outperformed its sector by 1.03%, suggesting some renewed buying interest. However, the broader trend remains subdued as the share price continues to trade below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a prevailing bearish momentum.</p>\n<p>Investor participation has increased, with delivery volumes rising by 52.1% to 2.91 lakh shares on 08 December compared to the five-day average. This heightened activity could be a sign o..."
      },
      {
        "title": "Cohance Lifesciences Stock Falls to 52-Week Low of Rs.521.45",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-stock-hits-52-week-low-amidst-continued-downtrend-3753682",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/CohanceLifescie_priceRelatedfactors_3753682.png",
        "date": "2025-12-09 10:47:42",
        "description": "Cohance Lifesciences has reached a new 52-week low, with its share price touching Rs.521.45 today. This marks a significant decline amid a broader market environment where the Sensex is trading lower, highlighting ongoing pressures within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Cohance Lifesciences Stock Falls to 52-Week Low of Rs.526.9",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-stock-hits-52-week-low-amidst-continued-downtrend-3751302",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/CohanceLifescie_priceRelatedfactors_3751302.png",
        "date": "2025-12-08 11:13:59",
        "description": "Cohance Lifesciences, a key player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.526.9 amid continued downward pressure on its stock price. This marks a significant milestone as the stock trades below all major moving averages, reflecting ongoing challenges in its market performance."
      },
      {
        "title": "Cohance Lifesciences Stock Falls to 52-Week Low of Rs.526.9 Amidst Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-stock-hits-52-week-low-amidst-continued-downtrend-3751298",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/CohanceLifescie_priceRelatedfactors_3751298.png",
        "date": "2025-12-08 11:13:56",
        "description": "Cohance Lifesciences has reached a new 52-week low of Rs.526.9, marking a significant decline in its stock price amid broader market fluctuations and sector underperformance. The stock has experienced a continued downward trend over the past two days, reflecting ongoing challenges within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Cohance Lifesciences Falls to 52-Week Low of Rs.526.9 Amidst Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-stock-hits-52-week-low-amidst-continued-downtrend-3751300",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/CohanceLifescie_priceRelatedfactors_3751300.png",
        "date": "2025-12-08 11:13:56",
        "description": "Cohance Lifesciences has reached a new 52-week low of Rs.526.9, marking a significant decline in its stock price amid broader market fluctuations and sector underperformance. The stock has experienced a continued downward trend over the past two days, reflecting ongoing challenges within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Cohance Lifesciences Stock Falls to 52-Week Low of Rs.526.9 Amidst Sector Underperformance",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-stock-hits-52-week-low-amidst-continued-downtrend-3751299",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/CohanceLifescie_priceRelatedfactors_3751299.png",
        "date": "2025-12-08 11:13:54",
        "description": "Cohance Lifesciences has reached a new 52-week low of Rs.526.9, marking a significant decline in its stock price as it continues to underperform within the Pharmaceuticals & Biotechnology sector. The stock's recent trajectory reflects ongoing challenges in both long-term and near-term financial metrics, contrasting with broader market trends."
      },
      {
        "title": "Cohance Lifesciences Stock Hits 52-Week Low at Rs.533.85 Amid Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-stock-hits-52-week-low-amidst-continued-downtrend-3748619",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/CohanceLifescie_priceRelatedfactors_3748619.png",
        "date": "2025-12-05 10:09:50",
        "description": "Cohance Lifesciences has reached a new 52-week low of Rs.533.85, marking a significant decline in its stock price amid broader market movements and sector-specific pressures. The stock's performance contrasts sharply with the overall market trend, reflecting ongoing challenges within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Cohance Lifesciences Stock Hits 52-Week Low at Rs.533.85 Amidst Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-stock-hits-52-week-low-amidst-continued-downtrend-3748617",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/CohanceLifescie_priceRelatedfactors_3748617.png",
        "date": "2025-12-05 10:09:45",
        "description": "Cohance Lifesciences has reached a new 52-week low of Rs.533.85, marking a significant decline in its stock price amid broader market movements and sectoral pressures. The stock’s performance contrasts sharply with the overall market trend, highlighting ongoing challenges within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Cohance Lifesciences Stock Hits 52-Week Low at Rs.540.5 Amidst Market Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cohance-lifesciences-stock-hits-52-week-low-amidst-continued-downtrend-3746264",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/CohanceLifescie_priceRelatedfactors_3746264.png",
        "date": "2025-12-04 10:19:15",
        "description": "Cohance Lifesciences has reached a new 52-week low of Rs.540.5, marking a significant decline in its stock price amid broader market movements and company-specific performance factors. This level reflects ongoing challenges in the pharmaceutical and biotechnology sector, with the stock trading below all key moving averages."
      }
    ],
    "total": 472,
    "sid": "1003386",
    "stock_news_url": "https://www.marketsmojo.com/news/cohance-lifesciences-1003386"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "13-Dec-2025",
      "details": "Schedule of the investors meet",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Change In Website Address Of The Company",
      "datetime": "13-Dec-2025",
      "details": "Intimation of change in website address of the Company",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "05-Dec-2025",
      "details": "Appointment of Senior Management Personnel",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Cohance Lifesciences Ltd has declared <strong>100%</strong> dividend, ex-date: 09 Sep 22",
          "dt": "2022-09-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Cohance Lifesciences Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 25 Sep 20",
          "dt": "2020-09-25",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Cohance Life falling/rising?

2025-12-10 00:56:29

Recent Price Dynamics and Market Context

On 09 December, Cohance Lifesciences demonstrated a slight recovery, gaining ₹4.80 or 0.9% after a period of downward pressure. Notably, the stock hit a fresh 52-week low of ₹521.45 during the day, signalling persistent weakness. Despite this, the stock outperformed its sector by 1.03%, suggesting some renewed buying interest. However, the broader trend remains subdued as the share price continues to trade below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a prevailing bearish momentum.

Investor participation has increased, with delivery volumes rising by 52.1% to 2.91 lakh shares on 08 December compared to the five-day average. This heightened activity could be a sign o...

Cohance Lifesciences Stock Falls to 52-Week Low of Rs.521.45

2025-12-09 10:47:42

Cohance Lifesciences has reached a new 52-week low, with its share price touching Rs.521.45 today. This marks a significant decline amid a broader market environment where the Sensex is trading lower, highlighting ongoing pressures within the Pharmaceuticals & Biotechnology sector.

Cohance Lifesciences Stock Falls to 52-Week Low of Rs.526.9

2025-12-08 11:13:59

Cohance Lifesciences, a key player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of Rs.526.9 amid continued downward pressure on its stock price. This marks a significant milestone as the stock trades below all major moving averages, reflecting ongoing challenges in its market performance.

Cohance Lifesciences Stock Falls to 52-Week Low of Rs.526.9 Amidst Market Pressure

2025-12-08 11:13:56

Cohance Lifesciences has reached a new 52-week low of Rs.526.9, marking a significant decline in its stock price amid broader market fluctuations and sector underperformance. The stock has experienced a continued downward trend over the past two days, reflecting ongoing challenges within the Pharmaceuticals & Biotechnology sector.

Cohance Lifesciences Falls to 52-Week Low of Rs.526.9 Amidst Market Pressure

2025-12-08 11:13:56

Cohance Lifesciences Stock Falls to 52-Week Low of Rs.526.9 Amidst Sector Underperformance

2025-12-08 11:13:54

Cohance Lifesciences has reached a new 52-week low of Rs.526.9, marking a significant decline in its stock price as it continues to underperform within the Pharmaceuticals & Biotechnology sector. The stock's recent trajectory reflects ongoing challenges in both long-term and near-term financial metrics, contrasting with broader market trends.

Cohance Lifesciences Stock Hits 52-Week Low at Rs.533.85 Amid Market Pressure

2025-12-05 10:09:50

Cohance Lifesciences has reached a new 52-week low of Rs.533.85, marking a significant decline in its stock price amid broader market movements and sector-specific pressures. The stock's performance contrasts sharply with the overall market trend, reflecting ongoing challenges within the Pharmaceuticals & Biotechnology sector.

Cohance Lifesciences Stock Hits 52-Week Low at Rs.533.85 Amidst Market Pressure

2025-12-05 10:09:45

Cohance Lifesciences has reached a new 52-week low of Rs.533.85, marking a significant decline in its stock price amid broader market movements and sectoral pressures. The stock’s performance contrasts sharply with the overall market trend, highlighting ongoing challenges within the Pharmaceuticals & Biotechnology sector.

Cohance Lifesciences Stock Hits 52-Week Low at Rs.540.5 Amidst Market Pressures

2025-12-04 10:19:15

Cohance Lifesciences has reached a new 52-week low of Rs.540.5, marking a significant decline in its stock price amid broader market movements and company-specific performance factors. This level reflects ongoing challenges in the pharmaceutical and biotechnology sector, with the stock trading below all key moving averages.